IVIg to Treat Severe Refractory HIT

CHEST Journal Podcasts
22/11/2017 37 min
IVIg to Treat Severe Refractory HIT

Listen "IVIg to Treat Severe Refractory HIT"

Descargar episodio Ver en sitio original

Episode Synopsis

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.

More episodes of the podcast CHEST Journal Podcasts

October 2025 CHEST Journal Editor Highlights 01/10/2025
The Frequency and Predictors of Pulmonary Rehabilitation Referrals Among Patients With Pulmonary Arterial Hypertension: An Analysis of the Pulmonary Hypertension Association Registry 01/10/2025
The Association Between Mechanical Power Within the First 24 Hours and ICU Mortality in Mechanically Ventilated Adult Patients With Acute Hypoxemic Respiratory Failure: A Registry-Based Cohort Study 01/10/2025
Humanities: Making Anger Count (Episode 3) 11/09/2025
September 2025 CHEST Journal Editor Highlights 01/09/2025
To Make a Self: Exploring and Supporting Professional Identity Formation and Resilience of Intensivists Through Humanities 01/09/2025
Impact of COVID-19 on Pulmonary Critical Care Fellows In-Training Exam Performance: A National Study 01/09/2025
August 2025 CHEST Journal Editor Highlights 01/08/2025
Inhaled Menthol for Dyspnea Relief During Cycle Exercise in COPD: A Randomized Trial 01/08/2025
July 2025 CHEST Journal Editor Highlights 01/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA